| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.
|
Eur J Cancer
|
2011
|
2.55
|
|
2
|
PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.
|
BMC Cancer
|
2011
|
1.73
|
|
3
|
Time-varying pattern of recurrence risk for Chinese breast cancer patients.
|
Breast Cancer Res Treat
|
2008
|
1.57
|
|
4
|
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
|
J Cancer Res Clin Oncol
|
2007
|
1.47
|
|
5
|
The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.
|
Breast Cancer Res Treat
|
2010
|
1.36
|
|
6
|
RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.
|
Clin Exp Metastasis
|
2007
|
1.29
|
|
7
|
Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials.
|
PLoS One
|
2011
|
1.27
|
|
8
|
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
|
Breast Cancer Res Treat
|
2011
|
1.22
|
|
9
|
Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy.
|
Cancer Lett
|
2011
|
0.97
|
|
10
|
TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade.
|
FEBS Lett
|
2007
|
0.97
|
|
11
|
Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.
|
BMC Cancer
|
2009
|
0.96
|
|
12
|
Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo.
|
Oncol Rep
|
2007
|
0.95
|
|
13
|
Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix.
|
Cancer Biol Ther
|
2007
|
0.94
|
|
14
|
An economic evaluation of adjuvant trastuzumab therapy in HER2-positive early breast cancer.
|
Value Health
|
2010
|
0.93
|
|
15
|
18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer.
|
J Nucl Med
|
2013
|
0.92
|
|
16
|
Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy.
|
Breast Cancer Res Treat
|
2013
|
0.92
|
|
17
|
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.
|
Breast Cancer Res Treat
|
2010
|
0.91
|
|
18
|
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis.
|
Clin Exp Metastasis
|
2013
|
0.90
|
|
19
|
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.
|
Pol J Pathol
|
2013
|
0.89
|
|
20
|
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.
|
Breast Cancer Res Treat
|
2012
|
0.88
|
|
21
|
Epidural Combined with General Anesthesia versus General Anesthesia Alone in Patients Undergoing Free Flap Breast Reconstruction.
|
Plast Reconstr Surg
|
2016
|
0.87
|
|
22
|
Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
|
OMICS
|
2009
|
0.87
|
|
23
|
Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer.
|
Int J Cancer
|
2014
|
0.86
|
|
24
|
Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomy.
|
Oncologist
|
2013
|
0.86
|
|
25
|
First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis.
|
PLoS One
|
2012
|
0.85
|
|
26
|
Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer.
|
BMC Cancer
|
2010
|
0.84
|
|
27
|
Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue.
|
J Exp Clin Cancer Res
|
2010
|
0.84
|
|
28
|
The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures.
|
Breast Cancer Res Treat
|
2011
|
0.84
|
|
29
|
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.
|
BMC Cancer
|
2014
|
0.84
|
|
30
|
Free Flap Monitoring Using Near-Infrared Spectroscopy: A Systemic Review.
|
Ann Plast Surg
|
2016
|
0.83
|
|
31
|
c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells.
|
Acta Biochim Biophys Sin (Shanghai)
|
2010
|
0.83
|
|
32
|
Prognostic and predictive value of TFF1 for adjuvant endocrine therapy in Chinese women with early ER positive breast cancer: comparing aromatase inhibitors with tamoxifen.
|
Breast
|
2010
|
0.83
|
|
33
|
An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study.
|
Cancer Chemother Pharmacol
|
2011
|
0.82
|
|
34
|
Rosiglitazone improves learning and memory ability in rats with type 2 diabetes through the insulin signaling pathway.
|
Am J Med Sci
|
2015
|
0.82
|
|
35
|
[Current trends of breast reconstruction after mastectomy for breast cancer patients in China: a survey report].
|
Zhonghua Zhong Liu Za Zhi
|
2014
|
0.81
|
|
36
|
[Sentinel lymph node biopsy in breast cancer].
|
Zhonghua Wai Ke Za Zhi
|
2002
|
0.81
|
|
37
|
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.
|
Cancer Chemother Pharmacol
|
2010
|
0.81
|
|
38
|
Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months.
|
BMC Cancer
|
2009
|
0.81
|
|
39
|
The clinical significance of Ki-67 as a marker of prognostic value and chemosensitivity prediction in hormone-receptor-positive breast cancer: a meta-analysis of the published literature.
|
Curr Med Res Opin
|
2013
|
0.81
|
|
40
|
Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
|
Cancer
|
2013
|
0.80
|
|
41
|
COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness.
|
Tumour Biol
|
2013
|
0.80
|
|
42
|
Using peripheral blood mRNA signature to distinguish between breast cancer and benign breast disease in non-conclusive mammography patients.
|
Cancer Biol Ther
|
2010
|
0.78
|
|
43
|
Postoperative fever: the potential relationship with prognosis in node negative breast cancer patients.
|
PLoS One
|
2010
|
0.77
|
|
44
|
Indispensability of chemotherapy in estrogen receptor-negative early breast cancer in elderly women with diabetes mellitus.
|
Diabetes Technol Ther
|
2015
|
0.77
|
|
45
|
External qigong therapy for women with breast cancer prior to surgery.
|
Integr Cancer Ther
|
2010
|
0.76
|
|
46
|
Combined effects of lapatinib and bortezomib in human epidermal receptor 2 (HER2)-overexpressing breast cancer cells and activity of bortezomib against lapatinib-resistant breast cancer cells.
|
Cancer Sci
|
2010
|
0.76
|
|
47
|
[Prediction value for dynamic changes of circulating tumor cell in therapeutic response and prognosis of Chinese metastatic breast cancer patients].
|
Zhonghua Yi Xue Za Zhi
|
2014
|
0.76
|
|
48
|
Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
49
|
Estimating cardiac substructures exposure from diverse radiotherapy techniques in treating left-sided breast cancer.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
50
|
A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer.
|
Cancer Biol Ther
|
2015
|
0.75
|
|
51
|
The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
52
|
The β-amyloid precursor protein analog P165 improves impaired insulin signal transduction in type 2 diabetic rats.
|
Neurol Sci
|
2014
|
0.75
|
|
53
|
[Lymphoscintigraphy in sentinel lymph node biopsy of breast cancer].
|
Zhonghua Zhong Liu Za Zhi
|
2002
|
0.75
|
|
54
|
Gene expression profiling in apoptotic k562 cells treated by homoharringtonine.
|
Acta Biochim Biophys Sin (Shanghai)
|
2007
|
0.75
|
|
55
|
[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer].
|
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
|
2015
|
0.75
|
|
56
|
[Effect of different estrogen receptor subtypes on vascular endothelial growth factor protein expression in human breast cancer samples].
|
Zhonghua Wai Ke Za Zhi
|
2002
|
0.75
|